FOXO3 and ovarian cancer: In addition, loss of functional FOXO3a in human ovarian cancer cell lines limited the sensitivity of ovarian cancer cells to chemotherapy, suggesting that FOXO proteins may be responsible for altered treatment outcomes in the presence of combined therapeutic approaches56.